What patients and families need to know
Participants Needed for Asthma Prevention Study
January 22, 2019
The Children's National IMPACT DC team is conducting the ORBEX study to assess the effectiveness of a medication in the prevention of infant wheezing. We are looking for healthy babies age 5-17 months who are at risk for developing asthma (as defined by having a parent or sibling over 4 years of age with asthma or eczema).
For more information, visit breatheeasyearly.info or contact: